Physician profile
Edward E Cherullo
NPI 1366468258
$16,202.16
in general payments reported to CMS, 2019-2025
17 companies · $3,328 in 2025
The $3,328 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $977 · 2020: $3,230 · 2021: $304 · 2022: $388 · 2023: $1,181 · 2024: $6,795 · 2025: $3,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,000 · Food and Beverage: $4,510 · Travel and Lodging: $1,793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,000.00 |
| Food and Beverage | $4,509.97 |
| Travel and Lodging | $1,793.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $5,032.44 | 2024 | |
| Intuitive Surgical, INC. | $4,823.21 | 2019-2025 | |
| Boston Scientific Corporation | $2,160.49 | 2019-2025 | Lithovue, Rezum Generator, General - Therapies |
| Procept Biorobotics Corporation | $1,315.63 | 2024-2025 | Aquabeam System |
| Olympus America INC. | $992.30 | 2022-2025 | Itind System, Soltive, Soltive |
| Urogen Pharma, INC. | $457.51 | 2025 | |
| Photocure INC | $323.93 | 2019-2023 | Cysview |
| Valencia Technologies Corporation | $212.40 | 2025 | Ecoin Device Kit |
| Edap Technomed INC | $180.95 | 2023 | |
| Sumitomo Pharma America, INC. | $163.69 | 2025 | Orgovyx |
| Travere Therapeutics, INC. | $161.82 | 2019 | |
| 180 Medical, INC. | $99.21 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $86.87 | 2021 | |
| Angiodynamics, INC. | $83.34 | 2019 | |
| Karl Storz Endoscopy-America | $60.41 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $31.36 | 2019 | |
| Ambu INC. | $16.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Cherullo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.